The 20 Best Teratoma of the Mediastinum Doctors Near Me in New York, US

Darren Feldman is an Oncologist practicing medicine in New York, New York. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Feldman is currently accepting new patients.

Joel Sheinfeld is a Urologist practicing medicine in New York, New York. Dr. Sheinfeld is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Teratoma of the Mediastinum, Choriocarcinoma, Orchiectomy, and Lymphadenectomy. Dr. Sheinfeld is currently accepting new patients.

Dean Bajorin is an Oncologist practicing medicine in New York, New York. Dr. Bajorin is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Bajorin is currently accepting new patients.

George Bosl is an Oncologist practicing medicine in New York, New York. Dr. Bosl is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Teratoma of the Mediastinum, Testicular Cancer, Mediastinal Tumor, Choriocarcinoma, and Orchiectomy.

. Dr. Bermejo is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

. Dr. Parylo is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC). Dr. Parylo is board certified in American Board Of Internal Medicine.

Martin Engelstein is a Urologist practicing medicine in Albany, New York. He has been practicing medicine for over 52 years. Dr. Engelstein is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Urothelial Cancer, and Ureteroscopy. Dr. Engelstein is board certified in American Board Of Urology. Dr. Engelstein is currently accepting new patients.

Dr. Saoud serves as an assistant professor of urology and urologic oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. His area of expertise includes the management of urological cancers such as prostate, kidney, bladder, testicular, and penile cancers, employing advanced surgical techniques like robotic, endoscopic, and open surgery. In addition to oncology, he addresses various urological conditions, including benign prostatic hyperplasia, erectile dysfunction, and kidney and bladder stones.Inspired by his family, many of whom are medical professionals, Dr. Saoud pursued a career in medicine, embodying the values of compassion and dedication he observed from an early age. His medical training began with a residency at the American University of Beirut Medical Center, completed in 2018, followed by specialized fellowship training in abdominal organ transplant and urologic oncology at the University of Chicago Medicine.Originating from Lebanon, Dr. Saoud has extended his commitment to healthcare through volunteer work, offering medical services to refugees and underserved populations. These experiences have profoundly influenced his approach to empathetic patient care.Dr. Saoud is dedicated to involving patients in their treatment planning, ensuring they are well-informed about their health options. He advocates for patient autonomy and individualized care, believing in the importance of preventive measures and a strong patient-provider relationship to achieve optimal health outcomes. Dr. Saoud is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Teratoma of the Mediastinum, Testicular Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Nephrectomy.

Thomas Bradley, MD, FACP, is Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As System Head for Genitourinary Cancers for the Northwell Health Cancer Institute, Dr. Bradley has special expertise in the management of prostate, kidney, bladder, and testicular cancers. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Bradley maintains an active practice where he focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. Dr. Bradley has a keen interest in the education of future physicians as evidenced by his directorship of the Fellowship program in Hematology and Medical Oncology for many years. His research work as principal investigator for numerous drug trials and multiple collaborations has resulted in dozens of publications and abstracts. Dr. Bradley earned his medical degree from the University of Monterrey School of Medicine. He trained in internal medicine as well as hematology and medical oncology at the State University of New York at Downstate Medical Center. Dr. Bradley is an active member of the American Society of Hematology, American Society of Clinical Oncology, American Association for Cancer Research and the American College of Physicians. Dr. Bradley is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, and Bone Marrow Aspiration. Dr. Bradley is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Nicholas Karanikolas is an Oncologist and a Urologist practicing medicine in Staten Island, New York. Dr. Karanikolas is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Ureteroscopy, and Prostatectomy. Dr. Karanikolas is board certified in American Board Of Urology.

Dr. Lerner received his Medical Degree with honors (cum laude) from the State University of New York Health Science Center at Brooklyn, New York. He was elected as a member to the Alpha Omega Alpha, Honor Medical Society. Dr. Lerner is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Lerner is board certified in American Board Of Urology.

Brett Carver is a Urologist practicing medicine in New York, New York. Dr. Carver is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Prostate Cancer, Teratoma of the Mediastinum, Orchiectomy, and Prostatectomy. Dr. Carver is currently accepting new patients.

Robert Motzer is an Oncologist practicing medicine in New York, New York. Dr. Motzer is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy. Dr. Motzer is currently accepting new patients.

Samuel Funt is an Oncologist practicing medicine in New York, New York. Dr. Funt is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Testicular Cancer, Teratoma of the Mediastinum, Bladder Cancer, and Orchiectomy. Dr. Funt is currently accepting new patients.

Deaglan Mchugh is an Oncologist practicing medicine in New York, New York. Dr. Mchugh is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Teratoma of the Mediastinum, and Prostatectomy. Dr. Mchugh is currently accepting new patients.

Joseph Jacob is a Urologist practicing medicine in Syracuse, New York. Dr. Jacob is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, PIK3CA-Related Overgrowth Spectrum, Cystectomy, and Ureteroscopy.

Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as an Advanced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Orchiectomy, and Nephrectomy. Dr. Tsao is board certified in American Board Of Internal Medicine/Medical Oncology.

Manpreet Kaur is a primary care provider, practicing in Geriatrics in Oyster Bay, New York. Dr. Kaur is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ectropion, Ludwig Angina, Acrospiroma, Cataract Removal, and Trabeculectomy. Dr. Kaur is board certified in American Board Of Internal Medicine.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.